EMM 210525

Drug Profile

EMM 210525

Alternative Names: E2/TX-525; EMM-210525; Estradiol/TX-525

Latest Information Update: 10 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Theramex SAM
  • Class Small molecules
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Menopausal syndrome

Most Recent Events

  • 10 May 2007 Discontinued - Phase-II for Menopausal syndrome in Europe (PO)
  • 15 Nov 2001 EMM 210525 is available for licensing in USA and Japan (http://www.theramex.mc)
  • 09 May 2001 Phase-II clinical trials for Menopausal syndrome in Europe (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top